Preferred Label : pyrroles;

MeSH definition : Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.;

MeSH synonym : Pyrrole;

Wikipedia automatic translation : Azole;

MeSH CAS label : 1-aza-2,4-cyclopentadiene;

Wikipedia link : https://en.wikipedia.org/wiki/Azole;

Is substance : O;

Details


Main resources

You can consult :

Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.

https://www.has-sante.fr/jcms/p_3242174/fr/ayvakyt
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
avapritinib
guidelines for drug use
gastrointestinal stromal tumors
adult
Metastatic Gastrointestinal Stromal Tumor
neoplasm metastasis
Unresectable Malignant Gastrointestinal Stromal Tumor
mutation
PDGFRA NP_006197.1:p.D842V
PDGFRA Gene Mutation
receptor, platelet-derived growth factor alpha
pyrazoles
pyrroles
triazines
protein kinase inhibitors
antineoplastic agents
evaluation of the transparency committee
avapritinib
avapritinib

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-les-resultats-preliminaires-dun-essai-clinique-indiquent-une-augmentation-du-risque-devenements-cardiovasculaires-et-de-tumeurs-malignes-en-comparaison-aux-anti-tnf-alpha
2021
false
false
false
France
French
clinical trials as topic
tofacitinib
neoplasms
cardiovascular diseases
risk
Janus Kinase Inhibitors
arthritis, rheumatoid
tofacitinib
pharmacovigilance note
pyrimidines
pyrroles
piperidines

---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75315a-fra.php
2021
false
false
false
Canada
French
English
drug information
tofacitinib
neoplasms
heart diseases
arthritis, rheumatoid
arthritis, psoriatic
administration, oral
colitis, ulcerative
pyrimidines
pyrroles
piperidines

---
https://ansm.sante.fr/tableau-atu-rtu/pemigatinib-4-5-mg-9-mg-et-13-5-mg-comprime
2021
false
false
false
France
French
package leaflet
summary of product characteristics
guidelines for drug use
administration, oral
morpholines
morpholines
pyrimidines
pyrimidines
pyrroles
pyrroles
pemigatinib
cholangiocarcinoma
adult
Locally Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma
cholangiocarcinoma
receptor, fibroblast growth factor, type 2
gene rearrangement
gene fusion
recurrence
Recurrent Cholangiocarcinoma
Refractory Cholangiocarcinoma
receptor, fibroblast growth factor, type 2
FGFR Inhibitor
Tyrosine Kinase Inhibitors
pemigatinib
pemigatinib

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-augmentation-du-risque-devenements-cardiovasculaires-indesirables-majeurs-et-de-tumeurs-malignes-avec-lutilisation-de-tofacitinib-en-comparaison-aux-antitnf-alpha
2021
false
false
false
France
French
pharmacovigilance note
tofacitinib
cardiovascular diseases
risk
neoplasms
tofacitinib
tofacitinib
arthritis, rheumatoid
major adverse cardiovascular events
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ayvakyt
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pyrazoles
pyrazoles
pyrroles
pyrroles
triazines
triazines
antineoplastic agents
antineoplastic agents
gastrointestinal stromal tumors
orphan drug production
neoplasm metastasis
mutation
gastrointestinal stromal tumors
receptor, platelet-derived growth factor alpha
administration, oral
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor
avapritinib
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
PDGFRA NP_006197.1:p.D842V
avapritinib
avapritinib

---
https://ansm.sante.fr/uploads/2020/10/30/20201030-dhpc-xeljanz.pdf
2020
false
false
false
France
French
tofacitinib
guidelines for drug use
administration, oral
protein kinase inhibitors
protein kinase inhibitors
risk factors
thrombosis
embolism and thrombosis
Drug-Related side effects and adverse reactions
tofacitinib
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
venous thromboembolism
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/jcms/c_2912419/fr/xeljanz
2019
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
tofacitinib
tofacitinib citrate
colitis, ulcerative
protein kinase inhibitors
janus kinases
adult
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
tofacitinib
pyrimidines
pyrroles
piperidines

---
https://www.ansm.sante.fr/actualites/restriction-dutilisation-du-xeljanz-tofacitinib
2019
false
false
false
France
French
guidelines for drug use
tofacitinib
protein kinase inhibitors
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
administration, oral
tofacitinib
pulmonary embolism
tofacitinib
protein kinase inhibitors
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-ne-plus-prescrire-10-mg-deux-fois-par-jour-chez-les-patients-ayant-un-risque-eleve-dembolie-pulmonaire
2019
false
false
false
France
French
administration, oral
tofacitinib
pharmacovigilance note
guidelines for drug use
pulmonary embolism
risk
arthritis, rheumatoid
tofacitinib
risk assessment
risk factors
tofacitinib
colitis, ulcerative
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.ansm.sante.fr/actualites/xeljanz-tofacitinib-lansm-demande-aux-professionnels-de-sante-et-aux-patients-de-bien-respecter-la-dose-autorisee-dans-le-traitement-de-la-polyarthrite-rhumatoide
2019
false
false
false
France
French
administration, oral
pharmacovigilance note
tofacitinib citrate
arthritis, rheumatoid
pulmonary embolism
tofacitinib citrate
tofacitinib
risk factors
tofacitinib
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69336a-fra.php
2019
false
false
false
Canada
French
English
pharmacovigilance note
arthritis, rheumatoid
tofacitinib
administration, oral
tofacitinib
protein kinase inhibitors
tofacitinib
pulmonary embolism
protein kinase inhibitors
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71766a-fra.php
2019
false
false
false
Canada
French
English
tofacitinib
thrombosis
risk
pharmacovigilance note
tofacitinib
pulmonary embolism
deep vein thrombosis
guidelines for drug use
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
risk factors
patients guideline
venous thrombosis
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_18_Spondyloarthrites_MAJ_220719.pdf
2019
false
false
false
France
adult
tofacitinib
tofacitinib
administration, oral
baricitinib
baricitinib
spondylitis, ankylosing
arthritis, psoriatic
guideline
Janus Kinase Inhibitors
spondylarthropathies
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_09_Digestif_Hepatiq_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
hepatic insufficiency
hepatitis B
hepatitis C
tofacitinib
baricitinib
Alanine aminotransferase outside reference range (finding)
transaminases
intestinal perforation
arthritis, rheumatoid
guideline
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_08_Aff%20Hemato_MAJ_200819.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
baricitinib
tofacitinib
Janus Kinase Inhibitors
risk factors
blood cell count
continuity of patient care
neutropenia
lymphopenia
anemia
algorithms
guideline
hematologic diseases
lymphoma
arthritis, rheumatoid
azetidines
sulfonamides
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_07_Cancer_MAJ_220719.pdf
2019
false
false
false
France
neoplasms
risk
Janus Kinase Inhibitors
Janus Kinase Inhibitors
tofacitinib
baricitinib
guideline
arthritis, rheumatoid
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_06_%20Cardio_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
cardiovascular agents
anticoagulants
tofacitinib
baricitinib
cholesterol
Janus Kinase Inhibitors
risk
risk factors
drug interactions
guideline
arthritis, rheumatoid
cardiovascular diseases
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.has-sante.fr/portail/jcms/c_2894923/en/xeljanz
2018
false
false
false
France
administration, oral
arthritis, psoriatic
adult
treatment outcome
insurance, health, reimbursement
protein kinase inhibitors
evaluation of the transparency committee
tofacitinib
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-patients-JAKi
2018
false
false
false
France
continuity of patient care
pregnancy
vaccination
travel
virus diseases
bacterial infections
cardiovascular diseases
neoplasms
lymphoma
digestive system diseases
hematologic diseases
dental care
surgical procedures, operative
tofacitinib
baricitinib
drug therapy, combination
arthritis, rheumatoid
Contraindications, Drug
drug interactions
Evidence-Based medicine
baricitinib
tofacitinib
guidelines for drug use
case management
Janus Kinase Inhibitors
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.ema.europa.eu/medicines/human/EPAR/Xeljanz
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tofacitinib
drug approval
europe
treatment outcome
tofacitinib
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
administration, oral
continuity of patient care
drug monitoring
janus kinases
pregnancy
breast feeding
drug interactions
protein kinase inhibitors
protein kinase inhibitors
product surveillance, postmarketing
aged
drug evaluation, preclinical
Product containing tofacitinib (medicinal product)
Tofacitinib 5mg tablet (product)
Tyrosine Kinase Inhibitors
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/portail/jcms/c_2798163/fr/xeljanz-tofacitinib-anti-jak-1-et-3
https://www.has-sante.fr/portail/jcms/c_2798163/fr/xeljanz
2017
false
false
false
France
French
tofacitinib
treatment outcome
tofacitinib
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
administration, oral
continuity of patient care
protein kinase inhibitors
protein kinase inhibitors
aged
Product containing tofacitinib (medicinal product)
Tofacitinib 5mg tablet (product)
guidelines for drug use
evaluation of the transparency committee
janus kinase 1
janus kinase 3
insurance, health, reimbursement
risk
Tyrosine Kinase Inhibitors
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
http://www.conseil-scientifique.public.lu/fr/publications/oncologie/sunitinib.html
2016
false
false
true
Luxembourg
French
guidelines for drug use
antineoplastic agents
administration, oral
sunitinib
protein kinase inhibitors
receptor Protein-Tyrosine kinases
treatment outcome
survival analysis
Progression-Free survival
kidney neoplasms
neoplasm metastasis
Metastatic Kidney Carcinoma
adult
gastrointestinal stromal tumors
pancreatic neoplasms
Pancreatic Neuroendocrine Tumor
neuroendocrine tumors
Advanced Malignant Neoplasm
Unresectable Malignant Neoplasm
Tyrosine Kinase Inhibitors
disease-free survival
indoles
pyrroles
Sunitinib

---
http://www.has-sante.fr/portail/jcms/c_2732140/fr/liptruzet
2016
false
false
false
France
French
evaluation of the transparency committee
liptruzet
azetidines
heptanoic acids
pyrroles
drug combinations

---
https://www.revmed.ch/RMS/2014/RMS-N-414/Rhumatologie-Une-nouvelle-option-therapeutique-dans-la-prise-en-charge-de-l-inflammation-chronique-en-rhumatologie-les-inhibiteurs-des-Janus-kinases
2014
false
false
false
Switzerland
piperidines
journal article
tofacitinib
protein kinase inhibitors
pyrimidines
pyrroles
tofacitinib
protein kinase inhibitors
piperidines
pyrimidines
pyrroles
arthritis, rheumatoid

---
http://unt-ori2.crihan.fr/unspf/2010_Lyon1_Nebois_heterocycliques_aromatiques_monocycliques.pdf
2010
true
false
true
France
educational course
education, pharmacy
chemistry, organic
imidazoles
heterocyclic compounds, 1-ring
pyrroles
pyridines

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.